SAO PAULO/ Brazilian company Precisa Medicamentos, representing India’s Bharat Biotech, on Monday said it requested that the country’s health regulator, Anvisa, grant emergency authorization to use the Covaxin COVID-19 vaccine.
In addition, it said Covaxin would be trialed in a Phase Three study in Brazil carried out in partnership with Sao Paulo’s Albert Einstein hospital.
- Trump Administration Ended Protetoin Status For Nepalese Migrants
- Jun 07, 2025
- DigitALL: Innovation And technology For Gender Equality
- Mar 08, 2023
- India Says It Will Protect Its Interests As Chinese Boat Heads To Sri Lanka
- Jul 30, 2022
- Omicron Poses 'Very High' Global Risk, World Must Prepare: WHO
- Nov 29, 2021
- Resumption Of India's COVAX Vaccine Supply Delayed By Nepal
- Nov 24, 2021
